We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$317M
AUM Growth
+$79.3M
Cap. Flow
+$66.9M
Cap. Flow %
21.11%
Top 10 Hldgs %
43.22%
Holding
98
New
36
Increased
16
Reduced
11
Closed
29

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$9.61M
2
BHC icon
Bausch Health
BHC
+$7.76M
3
MDT icon
Medtronic
MDT
+$7.64M
4
BIIB icon
Biogen
BIIB
+$6.02M
5
VTRS icon
Viatris
VTRS
+$5.3M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$13.7M
2
AGN
Allergan plc
AGN
+$7.44M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$6.22M
4
PBYI icon
Puma Biotechnology
PBYI
+$5.9M
5
ZBH icon
Zimmer Biomet
ZBH
+$5.88M

Sector Composition

Rank Sector Weight
1 Healthcare 67.88%
2 Technology 0.31%
3 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DERM
51
DELISTED
Dermira, Inc.
DERM
$1.4M 0.44%
80,000
– –
AFMD
52
DELISTED
Affimed
AFMD
$1.35M 0.42%
+10,000
New +$960K
HSTO
53
DELISTED
Histogen Inc. Common Stock
HSTO
$1.29M 0.41%
+1,250
New +$1.47M
ESPR
54
CALL
DELISTED
Esperion Therapeutics
ESPR
$1.23M 0.39%
+15,000
New +$1.47M
SCYX icon
55
SCYNEXIS
SCYX
$48.1M
$1.1M 0.35%
+1,563
New +$1.12M
ONCE
56
CALL
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$1.05M 0.33%
+17,500
New +$1.16M
DRNA
57
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.05M 0.33%
+75,000
New +$1.38M
GEN
58
DELISTED
Genesis Healthcare, Inc.
GEN
$990K 0.31%
+150,000
New +$1.01M
CSLT
59
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$977K 0.31%
120,000
-80,000
-40% -$667K
ONCE
60
PUT
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$904K 0.29%
+15,000
New +$992K
ETRM
61
DELISTED
EnteroMedics Inc.
ETRM
$667K 0.21%
1,024
-351
-26% -$404K
CBAY
62
DELISTED
Cymabay Therapeutics
CBAY
$646K 0.2%
240,000
-260,000
-52% -$1.07M
NVDQ
63
CALL
DELISTED
Novadaq Technologies Inc.
NVDQ
$606K 0.19%
+50,000
New +$597K
TVTY
64
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$599K 0.19%
+50,000
New +$830K
AVDL
65
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
$530K 0.17%
+25,000
New +$448K
LITS
66
Lite Strategy Inc
LITS
$30.7M
$428K 0.14%
12,500
+5,000
+67% +$195K
IMMU
67
CALL
DELISTED
Immunomedics Inc
IMMU
$305K 0.1%
+75,000
New +$307K
TCRT icon
68
PUT
Alaunos Therapeutics
TCRT
$4.81M
$300K 0.09%
+167
New +$259K
LITS
69
CALL
Lite Strategy Inc
LITS
$30.7M
$257K 0.08%
+7,500
New +$292K
ABBV icon
70
AbbVie
ABBV
$442B
– –
-50,000
Closed -$2.32M
ABT icon
71
Abbott
ABT
$190B
– –
-50,000
Closed -$2.4M
ASRT
72
DELISTED
Assertio
ASRT
– –
-417
Closed -$560K
AVDL
73
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-125,000
Closed -$2.24M
CAH icon
74
Cardinal Health
CAH
$55.9B
– –
-40,000
Closed -$3.61M
DOC icon
75
Healthpeak Properties
DOC
$14.1B
– –
-54,900
Closed -$2.16M
1 2
3
4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q2 2015 Portfolio in Review

As of Q2 2015, Iguana Healthcare Management held 98 positions worth $317M, up 33% from $238M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Iguana Healthcare Management deployed $66.9M of net new capital in Q2 2015, opening 36 new positions and adding to 16 existing holdings. Its largest new stake was Amgen: 60,000 shares worth $9.21M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, down from 82% a quarter earlier, followed by Technology and Real Estate.

On the sell side, the largest reduction was Pfizer, an estimated $13.7M trimmed.

  • Iguana Healthcare Management's largest Q2 2015 buy was Amgen: 60,000 shares worth $9.21M.
  • Iguana Healthcare Management added most to Elevance Health in Q2 2015, an estimated $4.79M increase.
  • Iguana Healthcare Management's biggest Q2 2015 reduction was Pfizer, cutting an estimated $13.7M.
  • Iguana Healthcare Management fully exited Allergan plc in Q2 2015, selling an estimated $7.44M.
  • Iguana Healthcare Management's ten largest holdings make up 43% of its $317M portfolio in Q2 2015.
  • Iguana Healthcare Management opened 36 new positions and closed 29 in Q2 2015.
  • Iguana Healthcare Management's portfolio value rose 33% quarter-over-quarter to $317M.

Based on Iguana Healthcare Management's 13F filing for Q2 2015, filed 14 Aug 2015.